Skip to main navigation
Skip to search
Skip to main content
King's College London Home
Home
Profiles
Research units
Research output
Projects
Student theses
Activities
Datasets
Impacts
Prizes
Search by expertise, name or affiliation
EGFR inhibition and more: a new generation growing up
Deborah Enting
,
James Spicer
*
*
Corresponding author for this work
Peter Gorer Department of Immunobiology
Comprehensive Cancer Centre
Research output
:
Contribution to journal
›
Editorial
›
peer-review
2
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'EGFR inhibition and more: a new generation growing up'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Therapeutic Procedure
100%
Disease
49%
Patient
49%
Protein Tyrosine Kinase
49%
Tyrosine-Kinase Inhibitor
49%
Non Small Cell Lung Cancer
49%
Epidermal Growth Factor Receptor Kinase Inhibitor
49%
Erlotinib
49%
Gefitinib
49%
Biochemistry, Genetics and Molecular Biology
Tyrosine Kinase
37%
Tyrosine Kinase Inhibitor
37%
Gefitinib
37%
Erlotinib
37%
Receptor Tyrosine Kinase Inhibitors
37%